Cargando…
Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities
Because of its high infectivity in humans and the lack of effective vaccines, Nipah virus is classified as a category C agent and handling has to be performed under biosafety level 4 conditions in non-endemic countries, which has hindered the development of vaccines. Based on a highly efficient pseu...
Autores principales: | Nie, Jianhui, Liu, Lin, Wang, Qing, Chen, Ruifeng, Ning, Tingting, Liu, Qiang, Huang, Weijin, Wang, Youchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455126/ https://www.ncbi.nlm.nih.gov/pubmed/30866781 http://dx.doi.org/10.1080/22221751.2019.1571871 |
Ejemplares similares
-
HIV-1 pseudoviruses constructed in China regulatory laboratory
por: Nie, Jianhui, et al.
Publicado: (2019) -
Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system
por: Nie, Jianhui, et al.
Publicado: (2017) -
Screening and identification of HTNV(pv) entry inhibitors with high-throughput pseudovirus-based chemiluminescence
por: Wen, Xiaojing, et al.
Publicado: (2022) -
Development of a Bioluminescent Imaging Mouse Model for SARS-CoV-2 Infection Based on a Pseudovirus System
por: Wu, Xi, et al.
Publicado: (2023) -
Editorial: Diagnosis of zoonoses: Relevance of BSL3 and BSL4 facilities
por: Berger, Kavita, et al.
Publicado: (2022)